Epigenetics is stream of genetics that comprises the study of how the cells control gene activity without altering the classification of DNA i.e., these amendments bring out only phenotypic variations in an organism rather than genotypic modification. Epigenetic variations are basically the modifications in DNA that control whether genes are turned on or off. these modifications are dynamic and are unchanging enough to pass from one generation to another.
According to the report analysis, ‘Epigenetics Market: Current Analysis and Forecast
(2021-2027)’ states that with speedy technological
advancement and growing investment in research & development of
pharmaceutical & biotechnology companies, the epigenetics market is observing
an uptick all over the globe. The effective growth in focus on epigenetics
research due to its wide scope of applications in non-oncology syndromes, customized
medicine, and targeted therapy, amongst other varied segments is influencing
the growth of this market. In addition, the epigenetics market is increasing
exponentially on account of growth in mortality rates and frequencies of cancer
and other chronic diseases coupled with the heavy requirement for medicines
across the globe.
Based on product, the market is classified into enzymes,
instruments, kits, reagents, and others. The kits segment created revenue of
USD XX million during 2020 and is predicted to develop at a CAGR of XX% during
the review period to reach a market valuation of USD XX million by 2027F due to
the growing implementation of epigenetics procedures and augment in launch of
new and advanced epigenetics kits. Based on the application, the market is categorized
into oncology, metabolic diseases, immunology, developmental biology,
cardiovascular diseases, and several others. The oncology segment registered
the market and created revenue of USD XX million during 2020 and manage its
dominance owing to the increasing usage of epigenetics in cancer research.
The epigenetics market is projected to witness a proficient market
growth throughout the forecast period, due to rise in pervasiveness of cancer, increment
in funding for R&D activities, growth in partnership amongst academic,
pharmaceutical, and biotechnology entities for epigenetics studies, and increment
in application of epigenetics in non-oncology diseases majorly propels the
market growth. However, great cost of instruments and shortage of trained
professionals are aspects that impede the market growth. Furthermore, growth
opportunities in emerging markets deliver the profitable opportunities to the
market players. Therefore, in the near years, it is predicted that the
market of epigenetics will increase around the globe more proficiently over the
near future.
For More Information, refer to
below link:-
Follow Us:-
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249